Haddad, Robert I.
1Dana-Farber/Brigham and Women's Cancer Center | Mass General Cancer Center,
United States
2025 Rank: 20,325
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 601 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20,325 | 22,584 |
| Total Cites | 3,531 | 3,721 |
| H-index | 28 | 28 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 417 | 432 |
| Number of Single+First+Last Authored Papers | 98 | 98 |
| Total Cites to Single+First+Last Authored Papers | 830 | 855 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,516 | 2,595 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.43 |
| Self-Citation Percentage |
5.11%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 1,301 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34,696 | 38,037 |
| Total Cites | 2,972 | 3,239 |
| H-index | 25 | 25 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 226 | 237 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 618 | 649 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,106 | 2,229 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.45 |
| Self-Citation Percentage |
8.24%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 1,061 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29,324 | 31,471 |
| Total Cites | 4,041 | 4,399 |
| H-index | 27 | 28 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 364 | 377 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 898 | 946 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,955 | 3,115 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.41 |
| Self-Citation Percentage |
8.14%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 1,088 out of 230,678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 30,785 | 34,227 |
| Total Cites | 2,760 | 3,044 |
| H-index | 22 | 22 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 214 | 222 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 589 | 633 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,043 | 2,157 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.41 |
| Self-Citation Percentage |
9.33%
|
|
Trending Researchers
.jpeg)
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.